Merck Cash on Hand 2010-2024 | MRK

Merck cash on hand for the quarter ending December 31, 2024 was $13.689B, a 92.99% increase year-over-year.

  • Merck cash on hand for 2024 was $13.689B, a 92.99% increase from 2023.
  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.

Merck Cash on Hand 2010-2024 | MRK

  • Merck cash on hand for 2024 was $13.689B, a 92.99% increase from 2023.
  • Merck cash on hand for 2023 was $7.093B, a 46.23% decline from 2022.
  • Merck cash on hand for 2022 was $13.192B, a 62.94% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Bayer (BAYRY)$22B
Innoviva (INVA)$1.1B